Paxman celebrates the passage of California AB 1682 legislation
The company supported the bill through legislative testimony. The measure expands scalp cooling access for chemotherapy patients.
See the latest news and media coverage for Paxman. We track all announcements, press releases, and industry mentions in real time, all in one place.
Scalp cooling and cryotherapy company
paxman.seLast updated
In short: Paxman achieved record-breaking financial results and secured legislative progress in the U.S. for scalp cooling insurance coverage.
The company supported the bill through legislative testimony. The measure expands scalp cooling access for chemotherapy patients.
The company reports US expansion, regulatory milestones for chemotherapy-induced peripheral neuropathy technology, and increased patient access.
CMS has proposed separate reimbursement for CPT code 97008 in OPPS and MPFS for 2027, but Paxman believes the levels are insufficient and will submit comments.
The certifications include UKCA, CE, ISO 13485 and MDSAP for prevention of chemotherapy-induced peripheral neuropathy.
Paxman breaks the 100 MSEK barrier for the first time in a record-breaking Q2! Figures in parentheses refer to the outcome for the corresponding period...
Paxman today announces a significant regulatory milestone in the development of its Limb Cryocompression System for the reduction of chemotherapy-induced peripheral neuropathy (CIPN), with the...
Figures in parentheses refer to the outcome for the corresponding period of the previous year. Dignitana has been part of the group since June 1...
A Calderdale health innovation helping patients manage anxiety during high-stress medical treatments such as chemotherapy has won £100,000 in the Mayor's Big Ideas Challenge.
Track Paxman and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Paxman and other trending companies.